Views & Analysis Despite progress, Brexit still threatens UK with relegation ... With time running out on Brexit, companies are already making long-term decisions.
News Is Lilly about to swoop on Verve Therapeutics? Ahead of an opt-in decision on a PCSK9 inhibitor candidate, Eli Lilly is reported to be in advanced takeover negotiations with Verve Therapeutics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
